<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>0</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>08</Month>
        <Day>20</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effects of Post-COVID-19 Conditions on Endometriosis</title>
    <FirstPage>1</FirstPage>
    <LastPage>15</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Matouri</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ameneh</FirstName>
        <LastName>Koochaki</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fahimeh</FirstName>
        <LastName>Ramezani Tehrani</LastName>
        <affiliation locale="en_US">Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology,  Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran AND Foundation for Research and Education Excellence, Vestavia Hills, Al, USA</affiliation>
      </Author>
      <Author>
        <FirstName>Shahla</FirstName>
        <LastName>Noori Ardebili</LastName>
        <affiliation locale="en_US">Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology,  Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Haji Molla Hoseini</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Marzieh</FirstName>
        <LastName>Saei Ghare Naz</LastName>
        <affiliation locale="en_US">Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology,  Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nariman</FirstName>
        <LastName>Mosaffa</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2026</Year>
        <Month>03</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>05</Month>
        <Day>21</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Evidence indicates that Long COVID is associated with menstrual cycle disruptions, hormonal changes, immune dysfunction, and persistent inflammation. Owing to these overlapping inflammatory mechanisms, Long COVID may aggravate endometriosis, potentially worsening pelvic pain and increasing the risk of developing the disease. We searched Scopus, PubMed, Google Scholar, and Science Direct for English-language articles from 2000 to 2024. After screening titles and abstracts, the authors assessed the full texts of potentially relevant studies. Studies were included if they provided robust, impactful data pertinent to the topic. Direct clinical evidence indicates that women with endometriosis report worsening of pelvic pain, dysmenorrhea, and fatigue after COVID-19, and that Long COVID causes menstrual cycle irregularities and chronic inflammation. Extrapolation of separate studies in Long COVID and endometriosis, several hypothesized mechanisms may contribute to symptom exacerbation: elevated C-X-C motif chemokine ligand 5 (CXCL5) and vascular endothelial growth factor (VEGF) may promote ectopic endometrial tissue growth and angiogenesis; neutrophil extracellular trap (NET) formation and extracellular matrix (ECM) alterations could further endometriosis progression; stress-related hormonal fluctuations may enlarge lesions; and altered pain perception and fatigue may limit beneficial physical activity. The long-term effects of COVID-19 could exacerbate the severity of endometriosis through several mechanisms.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4771</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4771/2393</pdf_url>
  </Article>
</Articles>
